Relevance of anti-inflammatory and antioxidant activities of exemestane and synergism with sulforaphane for disease prevention

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 47, 2013, Pages 19065-19070

  Liu, Hua ^a   Talalay, Paul ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ANASTROZOLE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; EXEMESTANE; FREE RADICAL; GLUTATHIONE; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LETROZOLE; LIPOPOLYSACCHARIDE; RALOXIFENE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 1; SULFORAPHANE; TAMOXIFEN; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CANCER; CELL LINE; CELL PROTECTION; CONTROLLED STUDY; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE PRODUCT; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION INJURY; RAT; REOXYGENATION; ULTRAVIOLET A RADIATION;

ANDROSTADIENES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELL LINE; CHRONIC DISEASE; CYTOPROTECTION; DRUG SYNERGISM; HUMANS; ISOTHIOCYANATES; LUCIFERASES; MICE; MICE, KNOCKOUT; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84888104450     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1318247110     Document Type: Article

References (40)

1. Fahey JW, Talalay P, Kensler TW (2012) Notes from the field: "Green" chemoprevention as frugal medicine. Cancer Prev Res (Phila) 5(2-179-188.
2. Kensler TW, et al. (2013) Keap1-nrf2 signaling: A target for cancer prevention by sulforaphane. Top Curr Chem 329:163-177.
3. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1- 11-30.
4. Dunn BK, Cazzaniga M, DeCensi A (2013) Exemestane: One part of the chemopreventive spectrum for ER-positive breast cancer. Breast 22(3-225-237.
5. Love RR, Hutson PR, Havighurst TC, Cleary JF (2005) Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer. Clin Cancer Res 11(4- 1500-1503.
6. Hong Y, et al. (2007) Molecular basis for the aromatization reaction and exemestanemediated irreversible inhibition of human aromatase. Mol Endocrinol 21(2-401-414.
7. Deeks ED, Scott LJ (2009) Exemestane: A review of its use in postmenopausal women with breast cancer. Drugs 69(7-889-918.
8. Goss PE, et al.; NCIC CTG MAP.3 Study Investigators (2011) Exemestane for breastcancer prevention in postmenopausal women. N Engl J Med 364(25-2381-2391.
9. Davidson NE, Kensler TW (2011) "MAPping" the course of chemoprevention in breast cancer. N Engl J Med 364(25-2463-2464.
10. Visvanathan K, et al. (2013) Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(23-2942-2962.
11. Hutson PR, Love RR, Havighurst TC, Rogers E, Cleary JF (2005) Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer. Clin Cancer Res 11(24 Pt 1-8722-8727.
12. Falandry C, Canney PA, Freyer G, Dirix LY (2009) Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Ann Oncol 20(4-615-620.
13. Giudici D, et al. (1988) 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304- A new irreversible aromatase inhibitor. J Steroid Biochem 30(1-6-391-394.
14. Talalay P, De Long MJ, Prochaska HJ (1988) Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc Natl Acad Sci USA 85(21-8261-8265.
15. Talalay P (2000) Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 12(1-4-5-11.
16. Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P (2001) Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 98(6- 3404-3409.
17. Dinkova-Kostova AT, et al. (2010) An exceptionally potent inducer of cytoprotective enzymes: Elucidation of the structural features that determine inducer potency and reactivity with Keap1. J Biol Chem 285(44-33747-33755.
18. Wakabayashi N, et al. (2004) Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 101(7-2040-2045.
19. Baird L, Dinkova-Kostova AT (2011) The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 85(4-241-272.
20. Zhang Y, Talalay P, Cho C-G, Posner GH (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc Natl Acad Sci USA 89(6-2399-2403.
21. Pezzuto JM, et al. (2005) Characterization of natural product chemopreventive agents. Cancer Chemoprevention 2: Strategies for Cancer Chemoprevention, eds Kelloff GJ, Hawk ET, Sigman CC (Humana, Totowa, NJ), pp 3-37.
22. Gao X, Dinkova-Kostova AT, Talalay P (2001) Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: The indirect antioxidant effects of sulforaphane. Proc Natl Acad Sci USA 98(26-15221-15226.
23. Gao X, Talalay P (2004) Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc Natl Acad Sci USA 101(28-10446-10451.
24. Svobodova A, Walterova D, Vostalova J (2006) Ultraviolet light induced alteration to the skin. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150(1-25-38.
25. Pinnell SR (2003) Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 48(1-1-19, quiz 20-22.
26. Dinkova-Kostova AT, et al. (2005) Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci USA 102(12-4584-4589.
27. Liu H, Dinkova-Kostova AT, Talalay P (2008) Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles. Proc Natl Acad Sci USA 105(41-15926-15931.
28. Chou T-C, Talalay P (1984) Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55.
29. Chou T-C, Martin N (2005) CompuSyn for drug combinations: A Computer Software for Quantitation of Synergism and Antagonism, and the Determination of IC50, ED50 and LD50 Values (ComboSyn, Paramus, NJ), [PC software and user's guide].
30. Chou T-C (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58(3- 621-681.
31. Tak PP, Firestein GS (2001) NF-kappaB: A key role in inflammatory diseases. J Clin Invest 107(1-7-11.
32. Gilroy DW, Lawrence T, Perretti M, Rossi AG (2004) Inflammatory resolution: New opportunities for drug discovery. Nat Rev Drug Discov 3(5-401-416.
33. Carlsen H, Moskaug JØ, Fromm SH, Blomhoff R (2002) In vivo imaging of NF-κB activity. J Immunol 168(3-1441-1446.
34. Adams LS, Chen S (2009) Phytochemicals for breast cancer prevention by targeting aromatase. Front Biosci (Landmark Ed) 14:3846-3863.
35. Dinkova-Kostova AT, Talalay P (2010) NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys 501(1-116-123.
36. Yao Y, Brodie AM, Davidson NE, Kensler TW, Zhou Q (2010) Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer. Breast Cancer Res Treat 124(2- 585-591.
37. Kobayashi M, et al. (2009) The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol 29(2-493-502.
38. McMahon M, Lamont DJ, Beattie KA, Hayes JD (2010) Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc Natl Acad Sci USA 107(44-18838-18843.
39. Wakabayashi N, Slocum SL, Skoko JJ, Shin S, Kensler TW (2010) When NRF2 talks, who's listening? Antioxid Redox Signal 13(11-1649-1663.
40. Liby KT, Sporn MB (2012) Synthetic oleanane triterpenoids: Multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol Rev 64(4-972-1003.